Lead party: British International Investment (BII) (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: mPharma Data, Inc. (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Malawi, Gabon, Zimbabwe, Kenya, Uganda, Ethiopia, Zambia, Rwanda, Nigeria, Ghana
Transaction type: Investment · Asset class: Venture Capital · Instrument: Ordinary Shares (Equity) · Round: Growth Capital · Deal amount: US$17m
Investors/buyers: British International Investment (BII), Daniel Vasella, Jim Breyer, Dompe Holdings
Legal advisers: not identified in the source record.
Source: announced 21 July 2022. Original announcement: qz.com.


